BioQuest Corp. (BQST)

USD 1.0

(-4.76%)

Operating Income Summary of BioQuest Corp.

BioQuest Corp.'s latest annual operating income in 2024 was -89.76 USD , up 99.82% from previous year.
BioQuest Corp.'s latest quarterly operating income in 2024 FY was -89.76 Thousand USD , down -82.96% from previous quarter.
BioQuest Corp. reported an annual operating income of -49.06 Thousand USD in 2023, up 94.0% from previous year.
BioQuest Corp. reported an annual operating income of -817.92 Thousand USD in 2022, up 62.83% from previous year.
BioQuest Corp. reported a quarterly operating income of -6500.00 USD for 2024 Q3, down -194.12% from previous quarter.
BioQuest Corp. reported a quarterly operating income of -74.23 Thousand USD for 2024 Q4, down -1042.0% from previous quarter.

Annual Operating Income Chart of BioQuest Corp. (2024 - 2012)

Historical Annual Operating Income of BioQuest Corp. (2024 - 2012)

Year	Operating Income	Operating Income Growth
2024	-89.76 USD	99.82%
2023	-49.06 Thousand USD	94.0%
2022	-817.92 Thousand USD	62.83%
2021	-2.2 Million USD	-517.17%
2020	-356.55 Thousand USD	-16255.69%
2019	-2180.00 USD	0.0%
2018	-2180.00 USD	0.0%
2014	-251.9 Thousand USD	-2943.41%
2013	-8277.00 USD	-341642.36%
2012	-2.42 USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	-2210.00 USD	67.31%
2024 Q3	-6500.00 USD	-194.12%
2024 Q4	-74.23 Thousand USD	-1042.0%
2024 Q1	-6760.00 USD	-146.24%
2024 FY	-89.76 Thousand USD	-82.96%
2023 Q1	-49.67 Thousand USD	78.39%
2023 Q2	1450.00 USD	102.92%
2023 Q4	14.62 Thousand USD	324.58%
2023 FY	-49.06 Thousand USD	94.0%
2023 Q3	-6510.00 USD	-548.97%
2022 Q4	-229.86 Thousand USD	-536.0%
2022 FY	-817.92 Thousand USD	62.83%
2022 Q3	52.72 Thousand USD	129.85%
2022 Q2	-176.63 Thousand USD	61.94%
2022 Q1	-464.14 Thousand USD	32.25%
2021 FY	-2.2 Million USD	-517.17%
2021 Q4	-685.12 Thousand USD	-21.34%
2021 Q3	-564.62 Thousand USD	10.26%
2021 Q1	-321.63 Thousand USD	-140.83%
2021 Q2	-629.17 Thousand USD	-95.62%
2020 Q2	-11.7 Thousand USD	35.61%
2020 FY	-356.55 Thousand USD	-16255.69%
2020 Q4	-133.55 Thousand USD	31.43%
2020 Q3	-194.76 Thousand USD	-1563.82%
2020 Q1	-18.18 Thousand USD	0.0%
2019 FY	-2180.00 USD	0.0%
2018 FY	-2180.00 USD	0.0%
2015 Q2	-890.04 Thousand USD	22.14%
2015 Q1	-1.14 Million USD	-371.48%
2015 Q3	-900.99 Thousand USD	-1.23%
2014 Q4	-242.44 Thousand USD	-20728.26%
2014 FY	-251.9 Thousand USD	-2943.41%
2014 Q3	-1164.00 USD	64.23%
2014 Q2	-3254.00 USD	35.49%
2014 Q1	-5044.00 USD	-112.83%
2013 Q4	-2370.00 USD	0.29%
2013 Q3	-2377.00 USD	27.35%
2013 Q2	-3272.00 USD	-1163.32%
2013 FY	-8277.00 USD	-341642.36%
2013 Q1	-259.00 USD	-64008.91%
2012 Q4	-0.40 USD	0.0%
2012 FY	-2.42 USD	0.0%

Peer Operating Income Comparison of BioQuest Corp.

Name	Operating Income	Operating Income Difference
GSRX Industries Inc.	- USD	Infinity%
High Sierra Technologies, Inc.	-238.36 Thousand USD	99.962%
Instadose Pharma Corp.	- USD	Infinity%